Although evidence has been indicated the potential benefits of BDS for those chronic diseases, especially COPD similar disease—asthma, there has not been any nationally representative studies to understand the patterns of BDS use and assess their impact on clinical outcomes and Hb level of patients with COPD in real-world settings. Here, GSTM1 is linked to chronic obstructive pulmonary disease.